Home LiteratureArticle Details
PMID: 346288 Published · ppublish English Journal Article Review

Individual differences in the disposition of drugs metabolised in the body.

Clinical pharmacokinetics ·Vol. 3 ·No. 2 ·1978-00-00 ·Pages 155-75

Alvan G

Abstract

暂无摘要

MeSH Terms
Alprenolol/metabolism Antipyrine/metabolism Biotransformation Dose-Response Relationship, Drug Humans Inactivation, Metabolic Indomethacin/metabolism Intestinal Mucosa/metabolism Isoniazid/metabolism Kinetics Liver/metabolism Nortriptyline/metabolism Pharmaceutical Preparations/metabolism Phenytoin/metabolism
Chemicals
Pharmaceutical Preparations Phenytoin Alprenolol Nortriptyline Antipyrine Isoniazid Indomethacin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Alvan G
References (90)
90 references, click to expand
  1. Clearance and biologic half-life as indices of intrinsic hepatic metabolism.
    J Pharmacol Exp Ther. 1974 Oct;191(1):17-24 PMID: 4423599
  2. Pharmacokinetics of fluoride in man after single and multiple oral doses.
    Eur J Clin Pharmacol. 1977 Dec 2;12(4):311-7 PMID: 590317
  3. Enhancement of the bioavailability of propranolol and metoprolol by food.
    Clin Pharmacol Ther. 1977 Jul;22(1):108-12 PMID: 872491
  4. Biliary excretion and enterochepatic recycling of proscillaridin A after oral adminstration to man.
    Eur J Clin Pharmacol. 1977 Apr 20;11(4):273-6 PMID: 862647
  5. The absorption of orally administered (12 - 3 H)digoxin in man.
    Clin Sci. 1972 Oct;43(4):507-18 PMID: 4653590
  6. Enterohepatic circulation of indomethacin and its role in intestinal irritation.
    Biochem Pharmacol. 1975 Oct 1;24(19):1749-54 PMID: 823946
  7. Fate of orally administered 3H-digitoxin in man with special reference to the absorption.
    Circulation. 1971 Jun;43(6):852-61 PMID: 5578859
  8. Abnormal pharmacokinetics of phenytoin in a patient with uraemia.
    Lancet. 1970 Oct 17;2(7677):831-2 PMID: 4196062
  9. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.
    Clin Pharmacol Ther. 1972 May-Jun;13(3):349-60 PMID: 5026376
  10. Tricyclic antidepressants. Prolonged plasma levels after overdose.
    JAMA. 1976 Oct 11;236(15):1711-2 PMID: 989517
  11. Influence of the route of administration on the area under the plasma concentration-time curve.
    J Pharm Sci. 1969 Jan;58(1):71-5 PMID: 5765841
  12. Metabolic fate of radioactive digitoxin in human subjects.
    J Pharmacol Exp Ther. 1955 Dec;115(4):371-9 PMID: 13272189
  13. Perfusion-limited of plasma drug binding on hepatic drug extraction.
    Life Sci. 1976 Jul 1;19(1):125-30 PMID: 940430
  14. Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.
    N Engl J Med. 1971 Jul 29;285(5):264-7 PMID: 4378402
  15. Pharmacokinetics of drugs in patients with the nephrotic syndrome.
    J Clin Invest. 1975 Jun;55(6):1182-9 PMID: 1133166
  16. First pass conjugation and enterohepatic recycling of oxazepam in dogs; intravenous tolerance of oxazepam in propylene glycol.
    Acta Pharmacol Toxicol (Copenh). 1977 Jan;40 Suppl 1(1):16-27 PMID: 300540
  17. Importance of "first-pass elimination" for interindividual differences in steady-state concentrations of the adrenergic beta-receptor antagonist alprenolol.
    J Pharmacokinet Biopharm. 1977 Jun;5(3):193-205 PMID: 881641
  18. Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin.
    Arch Neurol. 1960 Jun;2:624-30 PMID: 13805571
  19. Renal failure, drug pharmacokinetics and drug action.
    Clin Pharmacokinet. 1976;1(2):99-120 PMID: 13956
  20. First pass hydroxylation of nortriptyline: concentrations of parent drug and major metabolites in plasma.
    Eur J Clin Pharmacol. 1977 Mar 11;11(3):219-24 PMID: 852498
  21. Plasma propranolol levels in adults with observations in four children.
    Clin Pharmacol Ther. 1970 Jan-Feb;11(1):112-20 PMID: 5410893
  22. Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect.
    Clin Pharmacol Ther. 1976 May;19(5 Pt 1):552-8 PMID: 1277711
  23. Quantitative determination of imipramine and desipramine in human blood plasma by direct densitometry of thin-layer chromatograms.
    J Pharm Pharmacol. 1973 Aug;25(8):599-603 PMID: 4148426
  24. Nonlinear relationship between plasma and red blood cell pharmacokinetics of chlorthalidone in man.
    J Pharmacokinet Biopharm. 1977 Aug;5(4):359-75 PMID: 894487
  25. Steady-state plasma concentrations of alprenolol in man.
    Eur J Clin Pharmacol. 1974 Aug 23;7(5):353-6 PMID: 4419005
  26. Rapidly achieved plasma concentration plateaus, with observations on theophylline kinetics.
    Clin Pharmacol Ther. 1972 May-Jun;13(3):329-35 PMID: 5026374
  27. Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation.
    Res Commun Chem Pathol Pharmacol. 1972 May;3(3):455-66 PMID: 5034507
  28. Undernutrition and tetracycline half life.
    Clin Chim Acta. 1976 Jan 16;66(2):157-64 PMID: 1245065
  29. Proceedings: "First-pass" effect and dose dependent availability as factors contributing to interindividual differences in equilibrium concentrations of alprenolol in man.
    Acta Pharm Suec. 1974 Dec;11(6):649-50 PMID: 1136801
  30. Influence of route of administration on drug availability.
    J Pharm Sci. 1972 Jan;61(1):70-4 PMID: 5019220
  31. Enhanced phenacetin metabolism in human subjects fed charcoal-broiled beef.
    Clin Pharmacol Ther. 1976 Dec;20(6):633-42 PMID: 991534
  32. Pharmacokinetics of nortriptyline in man after single and multiple oral doses: the predictability of steady-state plasma concentrations from single-dose plasma-level data.
    Eur J Clin Pharmacol. 1972 Mar;4(2):82-91 PMID: 4655685
  33. Blood levels of drug at the equilibrium state after multiple dosing.
    Nature. 1965 Sep 18;207(5003):1301-2 PMID: 5884654
  34. The disposition of sulindac.
    Clin Pharmacol Ther. 1977 Mar;21(3):326-35 PMID: 300048
  35. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.
    J Pharmacokinet Biopharm. 1977 Oct;5(5):445-79 PMID: 925881
  36. Microsomal enzymes in malnutrition as determined by plasma half life of antipyrine.
    Br Med J. 1977 Feb 26;1(6060):538-40 PMID: 843795
  37. Diphenylhydantoin elimination kinetics in overdosed children.
    Clin Pharmacol Ther. 1975 Apr;17(4):481-91 PMID: 1122689
  38. Individual differences in the pharmacokinetics of monomethylated tricyclic antidepressants: role of genetic and environmental factors and clinical importance.
    Ann N Y Acad Sci. 1971 Jul 6;179:739-51 PMID: 5285398
  39. Gas chromatographic assessment of the reproducibility of phenazone plasma half-life in young healthy volunteers.
    Eur J Clin Pharmacol. 1974 Aug 23;7(5):381-5 PMID: 4418356
  40. Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.
    Clin Pharmacokinet. 1976 Nov-Dec;1(6):444-52 PMID: 1024769
  41. Acute intoxication with 5,5-diphenylhydantoin (Dilantin) associated with impairment of biotransformation. Plasma levels and urinary metabolites; and studies in healthy volunteers.
    Ann Intern Med. 1972 Nov;77(5):765-71 PMID: 4628215
  42. Nonlinear assessment of phenytoin bioavailability.
    J Pharmacokinet Biopharm. 1976 Aug;4(4):327-36 PMID: 978395
  43. Influence of first-pass effect on availability of drugs on oral administration.
    J Pharm Sci. 1971 Sep;60(9):1338-40 PMID: 5567579
  44. Pharmacokinetics of theophylline in children with asthma.
    Pediatrics. 1976 Oct;58(4):542-7 PMID: 972795
  45. Serum-phenytoin levels in management of epilepsy.
    Lancet. 1975 Aug 9;2(7928):247-8 PMID: 49797
  46. Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution.
    Clin Pharmacol Ther. 1970 Nov-Dec;11(6):846-55 PMID: 4394754
  47. Failure of vitamin C to affect the pharmacokinetic profile of antipyrine in man.
    J Clin Pharmacol. 1976 May-Jun;16(5-6):265-70 PMID: 1262536
  48. Commentary: a physiological approach to hepatic drug clearance.
    Clin Pharmacol Ther. 1975 Oct;18(4):377-90 PMID: 1164821
  49. Transport and binding of methotrexate in vivo.
    J Pharm Sci. 1973 Jun;62(6):882-90 PMID: 4712617
  50. System for clinical pharmacokinetic monitoring of theophylline therapy.
    Am J Hosp Pharm. 1976 Sep;33(9):949-56 PMID: 790952
  51. The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.
    J Pharmacol Exp Ther. 1973 Jul;186(1):114-22 PMID: 4198771
  52. Prediction of steady-state plasma levels of nortriptyline from single oral dose kinetics: a study in twins.
    Eur J Clin Pharmacol. 1973 Jun;6(1):44-53 PMID: 4797180
  53. Effect of environmental factors on drug metabolism: decreased plasma half-life of antipyrine in workers exposed to chlorinated hydrocarbon insecticides.
    Clin Pharmacol Ther. 1969 Sep-Oct;10(5):638-42 PMID: 5808460
  54. Pharmacokinetics of oxazepam in healthy volunteers.
    Acta Pharmacol Toxicol (Copenh). 1977 Jan;40 Suppl 1(1):40-51 PMID: 300541
  55. Pharmacokinetics of intravenous theophylline.
    Clin Pharmacol Ther. 1973 Jul-Aug;14(4):509-13 PMID: 4723258
  56. Genetic control of isoniazid metabolism in man.
    Br Med J. 1960 Aug 13;2(5197):485-91 PMID: 13820968
  57. Plasma levels of imipramine and desmethylimipramine during therapy.
    Br J Psychiatry. 1967 Feb;113(495):183-93 PMID: 6032479
  58. Amoxycillin: A review of its antibacterial and pharmacokinietic properties and therapeutic use.
    Drugs. 1975;9(2):88-140 PMID: 1126306
  59. Clearance concepts in pharmacokinetics.
    J Pharmacokinet Biopharm. 1973 Apr;1(2):123-36 PMID: 4764426
  60. Anticonvulsant effect of diphenylhydantoin relative to plasma levels. A prospective three-year study in ambulant patients with generalized epileptic seizures.
    Arch Neurol. 1974 Nov;31(5):289-94 PMID: 4212949
  61. Letter: Effect of plasma protein binding on elimination of warfarin.
    J Pharm Sci. 1974 May;63(5):805-6 PMID: 4830012
  62. The effects of age and liver disease on the disposition and elimination of diazepam in adult man.
    J Clin Invest. 1975 Feb;55(2):347-59 PMID: 1127104
  63. Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes.
    Clin Pharmacokinet. 1977 Jan-Feb;2(1):45-60 PMID: 322910
  64. Intrasubject variation in elimination half-lives of drugs which are appreciably metabolized.
    J Pharmacokinet Biopharm. 1973 Apr;1(2):165-73 PMID: 4797185
  65. Pharmacokinetics of drug disposition: hemodynamic considerations.
    Annu Rev Pharmacol. 1975;15:11-27 PMID: 1096786
  66. First-pass metabolism of nortriptyline in man.
    Clin Pharmacol Ther. 1975 Sep;18(3):305-14 PMID: 1164819
  67. Biliary elimination of diazepam in man.
    Clin Pharmacol Ther. 1976 Apr;19(4):443-50 PMID: 1269195
  68. Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance.
    J Pharmacol Exp Ther. 1977 Feb;200(2):420-4 PMID: 839445
  69. Biliary excretion of digoxin in man.
    Clin Pharmacol Ther. 1976 Apr;19(4):410-5 PMID: 942606
  70. DIPHENYLHYDANTOIN METABOLISM, BLOOD LEVELS, AND TOXICITY.
    Arch Neurol. 1964 Dec;11:642-8 PMID: 14202181
  71. Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds.
    Life Sci. 1967 Sep 1;6(17):1895-903 PMID: 6052684
  72. Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man.
    Clin Pharmacol Ther. 1973 Jul-Aug;14(4):494-500 PMID: 4723256
  73. Elimination of antipyrine from saliva as a measure of metabolism in man.
    Clin Pharmacol Ther. 1975 Sep;18(3):249-58 PMID: 1164815
  74. Pharmacokinetics of indomethacin.
    Clin Pharmacol Ther. 1975 Sep;18(3):364-73 PMID: 1100305
  75. AMPICILLIN LEVELS IN HUMAN BILE.
    Br J Pharmacol Chemother. 1965 Feb;24:189-93 PMID: 14306010
  76. Amobarbital--a probe of hepatic drug oxidation in man.
    Clin Pharmacol Ther. 1976 Oct;20(4):439-44 PMID: 975717
  77. Protein binding and kinetics of drugs in liver diseases.
    Clin Pharmacokinet. 1977 Jan-Feb;2(1):32-44 PMID: 322909
  78. Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking.
    Clin Pharmacol Ther. 1975 Oct;18(4):425-32 PMID: 1164824
  79. Influence of first-pass effect on the systemic availability of propoxyphene.
    J Clin Pharmacol New Drugs. 1972 Nov-Dec;12(11):449-52 PMID: 4484660
  80. Effect of pentobarbital on the disposition of alprenolol.
    Clin Pharmacol Ther. 1977 Sep;22(3):316-21 PMID: 891097
  81. Physiological and pharmacokinetic complexities in bioavailability testing.
    Pharmacology. 1972;8(1):118-41 PMID: 4644643
  82. Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease.
    Gut. 1972 Jan;13(1):47-53 PMID: 5060669
  83. The metabolism of fluorides in man.
    AMA Arch Ind Health. 1960 Apr;21:318-23 PMID: 14414185
  84. Genetic study of amobarbital elimination based on its kinetics in twins.
    Clin Pharmacol Ther. 1976 Dec;20(6):701-14 PMID: 1033050
  85. Elimination of antipyrine and benzo[a]pyrene metabolism in cultured human lymphocytes.
    Clin Pharmacol Ther. 1976 Jul;20(1):72-80 PMID: 1277727
  86. Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man.
    Clin Pharmacol Ther. 1976 Dec;20(6):643-53 PMID: 991535
  87. A comparative study of drug metabolism in the isolated perfused liver and in vivo in rats.
    Eur J Pharmacol. 1970 Jan;9(1):99-105 PMID: 5434299
  88. Disease and acetylation polymorphism.
    Clin Pharmacokinet. 1977 May-Jun;2(3):182-97 PMID: 328206
  89. Altered hepatic blood flow and drug disposition.
    Clin Pharmacokinet. 1976;1(2):135-55 PMID: 13954
  90. Frequency distribution of free warfarin and free phenytoin fraction values in serum of healthy human adults.
    Clin Pharmacol Ther. 1977 Mar;21(3):283-6 PMID: 837646
Article Info
Journal
Clinical pharmacokinetics
Abbr.
Clin Pharmacokinet
ISSN
0312-5963
DOI
10.2165/00003088-197803020-00005
Published
1978-00-00
Pages
155-75
Language
English
Region
Switzerland
NLM ID
7606849
Subset
IM
External Links
PubMed source DOI: 10.2165/00003088-197803020-00005 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2